fda tirzepatide injection shortage resolved october 2 2024 Says Compounded Must Exit the Market FDA Affirms Decision on Tirzepatide

For the regulatory framework for tirzepatide in Germany more broadly, including import rules and grey-market risks, see the tirzepatide Germany import rules article

For recurrent injection site reactions that occur with every dose, schedule a non-urgent appointment with your healthcare provider or diabetes care and education specialist (CDCES)

Here is what the timeline typically looks like for men, drawn from trial data, real-world reports, and community feedback from forums and tracking platforms

Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity - Frontiers in Endocrinology Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity - JAMA Internal Medicine Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes - New England Journal of Medicine Tirzepatide for Diabetes Improves Glycemic Control After Switch From GLP-1RA - Endocrinology Advisor Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension - Diabetes, Obesity and Metabolism